aTyr Pharma, Inc. (ATYR)
3.82
+0.13
(+3.52%)
USD |
NASDAQ |
Nov 20, 16:00
3.80
-0.02
(-0.52%)
After-Hours: 20:00
aTyr Pharma EPS Diluted (Quarterly) : -7.433 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -7.433 |
| June 30, 2026 | -4.205 |
| March 31, 2026 | -4.402 |
| December 31, 2025 | -5.698 |
| September 30, 2025 | -10.60 |
| June 30, 2025 | -8.669 |
| March 31, 2025 | -6.882 |
| December 31, 2024 | -7.237 |
| September 30, 2024 | -9.108 |
| June 30, 2024 | -9.023 |
| March 31, 2024 | -9.377 |
| December 31, 2023 | -9.963 |
| September 30, 2023 | -7.836 |
| June 30, 2023 | -8.950 |
| March 31, 2023 | -11.41 |
| December 31, 2022 | -10.33 |
| September 30, 2022 | -18.48 |
| June 30, 2022 | -17.70 |
| March 31, 2022 | -17.47 |
| December 31, 2021 | -12.32 |
| September 30, 2021 | -16.89 |
| June 30, 2021 | -25.77 |
| March 31, 2021 | -20.28 |
| December 31, 2020 | -18.66 |
| Date | Value |
|---|---|
| September 30, 2020 | -27.36 |
| June 30, 2020 | -27.55 |
| March 31, 2020 | 10.18 |
| December 31, 2019 | -61.40 |
| September 30, 2019 | -58.71 |
| June 30, 2019 | -1009.23 |
| March 31, 2019 | -101.61 |
| December 31, 2018 | -116.74 |
| September 30, 2018 | -133.43 |
| June 30, 2018 | -195.38 |
| March 31, 2018 | -200.49 |
| December 31, 2017 | -218.40 |
| September 30, 2017 | -240.80 |
| June 30, 2017 | -285.60 |
| March 31, 2017 | -313.60 |
| December 31, 2016 | -296.80 |
| September 30, 2016 | -324.80 |
| June 30, 2016 | -364.00 |
| March 31, 2016 | -380.80 |
| December 31, 2015 | -392.00 |
| September 30, 2015 | -268.80 |
| June 30, 2015 | -414.40 |
| March 31, 2015 | -217.52 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | -0.0232 |
| Savara, Inc. | -0.1691 |
| Arrowhead Pharmaceuticals, Inc. | -3.029 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.26M |
| Total Expenses (Quarterly) | 18.26M |
| Enterprise Value | -28.43M |
| Earnings Yield | -569.1% |
| Normalized Earnings Yield | -569.09 |